AAAAAA
Results: 1-25/256
Authors:
MUNRO S
MICKELSEN PA
ANDERSON M
WILSON ML
ROBINSON A
WALSH P
MEIER FA
CAMPOS JM
HACEK DM
PETERSON LR
REYNOLDS JK
ALLEN SD
PFALLER MA
JONES RN
VALENSTEIN P
COCKERILL F
GILLIGAN PH
WAIT K
HARRELL LJ
RELLER LB
WASHINGTON JA
MANN LM
WOODS GL
CARROLL KC
REIMER L
Citation: S. Munro et al., UNITED-STATES GEOGRAPHIC BACTERIA SUSCEPTIBILITY PATTERNS, AJCP. American journal of clinical pathology, 109(2), 1998, pp. 144-152
Authors:
WINOKUR PL
PFALLER MA
JONES RN
Citation: Pl. Winokur et al., EVALUATION OF KLEBSIELLA PNEUMONIA ISOLATES OBTAINED FROM 4 CONTINENTS WHICH EXPRESS EXTENDED-SPECTRUM BETA-LACTAMASES, Journal of investigative medicine, 46(7), 1998, pp. 286-286
Authors:
HUGHES JM
WEILL H
CHECKOWAY H
JONES RN
HENRY MM
HEYER NJ
SEIXAS NS
DEMERS PA
Citation: Jm. Hughes et al., RADIOGRAPHIC EVIDENCE OF SILICOSIS RISK IN THE DIATOMACEOUS-EARTH INDUSTRY, American journal of respiratory and critical care medicine, 158(3), 1998, pp. 807-814
Authors:
DOERN GV
PFALLER MA
KUGLER K
FREEMAN J
JONES RN
Citation: Gv. Doern et al., PREVALENCE OF ANTIMICROBIAL RESISTANCE AMONG RESPIRATORY-TRACT ISOLATES OF STREPTOCOCCUS-PNEUMONIAE IN NORTH-AMERICA - 1997 RESULTS FROM THE SENTRY ANTIMICROBIAL SURVEILLANCE PROGRAM, Clinical infectious diseases, 27(4), 1998, pp. 764-770
Authors:
JONES RN
MILAZZO J
SEIDLIN M
Citation: Rn. Jones et al., OFLOXACIN OTIC SOLUTION FOR TREATMENT OF OTITIS-EXTERNA IN CHILDREN AND ADULTS (VOL 123, PG 1193, 1997), Archives of otolaryngology, head & neck surgery, 124(6), 1998, pp. 711-711
Authors:
JONES RN
MARSHALL SA
VARNAM DJ
Citation: Rn. Jones et al., ACTIVITY OF A BROAD-SPECTRUM CEPHALOSPORIN (RO-48-8391) ALONE AND IN COMBINATION WITH 2 NOVEL BETA-LACTAMASE INHIBITORS (RO-48-5545 AND RO-48-8724), Diagnostic microbiology and infectious disease, 32(2), 1998, pp. 85-94
Authors:
JONES RN
BIEDENBACH DJ
MARSHALL SA
PFALLER MA
DOERN GV
Citation: Rn. Jones et al., EVALUATION OF THE VITEK SYSTEM TO ACCURATELY TEST THE SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA CLINICAL ISOLATES AGAINST CEFEPIME, Diagnostic microbiology and infectious disease, 32(2), 1998, pp. 107-110
Authors:
JONES RN
PFALLER MA
DOERN GV
Citation: Rn. Jones et al., COMPARATIVE ANTIMICROBIAL ACTIVITY OF TROVAFLOXACIN TESTED AGAINST 3049 STREPTOCOCCUS-PNEUMONIAE ISOLATES FROM THE 1997-1998 RESPIRATORY-INFECTION SEASON, Diagnostic microbiology and infectious disease, 32(2), 1998, pp. 119-126
Authors:
DIPERSIO JR
JONES RN
BARRETT T
DOERN GV
PFALLER MA
Citation: Jr. Dipersio et al., FLUOROQUINOLONE-RESISTANT MORAXELLA-CATARRHALIS IN A PATIENT WITH PNEUMONIA - REPORT FROM THE SENTRY ANTIMICROBIAL SURVEILLANCE PROGRAM (1998), Diagnostic microbiology and infectious disease, 32(2), 1998, pp. 131-135
Authors:
MARCO F
PFALLER MA
MESSER SA
JONES RN
Citation: F. Marco et al., ACTIVITY OF MK-0991 (L-743,872), A NEW ECHINOCANDIN, COMPARED WITH THOSE OF LY303366 AND 4 OTHER ANTIFUNGAL AGENTS TESTED AGAINST BLOOD-STREAM ISOLATES OF CANDIDA SPP, Diagnostic microbiology and infectious disease, 32(1), 1998, pp. 33-37
Authors:
BIEDENBACH DJ
BARRETT MS
CROCO MAT
JONES RN
Citation: Dj. Biedenbach et al., BAY 12-8039, A NOVEL FLUOROQUINOLONE ACTIVITY AGAINST IMPORTANT RESPIRATORY-TRACT PATHOGENS, Diagnostic microbiology and infectious disease, 32(1), 1998, pp. 45-50
Authors:
JONES RN
ERWIN ME
Citation: Rn. Jones et Me. Erwin, IN-VITRO SUSCEPTIBILITY TESTING AND QUALITY-CONTROL PARAMETERS FOR SARAFLOXACIN (A-56620) - A FLUOROQUINOLONE USED FOR TREATMENT AND CONTROL OF COLIBACILLOSIS IN POULTRY, Diagnostic microbiology and infectious disease, 32(1), 1998, pp. 55-64
Authors:
JONES RN
BIEDENBACH DJ
CROCO MAT
BARRETT MS
Citation: Rn. Jones et al., IN-VITRO EVALUATION OF A NOVEL ORALLY-ADMINISTERED CEPHALOSPORIN (CEFDITOREN) TESTED AGAINST 1249 RECENT CLINICAL ISOLATES OF HAEMOPHILUS-INFLUENZAE, MORAXELLA-CATARRHALIS, AND STREPTOCOCCUS-PNEUMONIAE, Diagnostic microbiology and infectious disease, 31(4), 1998, pp. 573-578
Authors:
JONES RN
BALLOW CH
BIEDENBACH DJ
DEINHART JA
SCHENTAG JJ
Citation: Rn. Jones et al., ANTIMICROBIAL ACTIVITY OF QUINUPRISTIN-DALFOPRISTIN (RP-59500, SYNERCID(R)) TESTED AGAINST OVER 28,000 RECENT CLINICAL ISOLATES FROM 200 MEDICAL-CENTERS IN THE UNITED-STATES AND CANADA, Diagnostic microbiology and infectious disease, 31(3), 1998, pp. 437-451
Authors:
JONES RN
WILSON WR
Citation: Rn. Jones et Wr. Wilson, EPIDEMIOLOGY, LABORATORY DETECTION, AND THERAPY OF PENICILLIN-RESISTANT STREPTOCOCCAL INFECTIONS, Diagnostic microbiology and infectious disease, 31(3), 1998, pp. 453-459
Authors:
JONES RN
Citation: Rn. Jones, IMPORTANT AND EMERGING BETA-LACTAMASE-MEDIATED RESISTANCES IN HOSPITAL-BASED PATHOGENS - THE AMP-C ENZYMES, Diagnostic microbiology and infectious disease, 31(3), 1998, pp. 461-466
Authors:
BIEDENBACH DJ
BARRETT MS
JONES RN
Citation: Dj. Biedenbach et al., COMPARATIVE ANTIMICROBIAL ACTIVITY AND KILL-CURVE INVESTIGATIONS OF NOVEL KETOLIDE ANTIMICROBIAL AGENTS (HMR-3004 AND HMR-3647) TESTED AGAINST HAEMOPHILUS-INFLUENZAE AND MORAXELLA-CATARRHALIS STRAINS, Diagnostic microbiology and infectious disease, 31(2), 1998, pp. 349-353
Authors:
JONES RN
JOHNSON DM
Citation: Rn. Jones et Dm. Johnson, COMBINATIONS OF ORALLY-ADMINISTERED BETA-LACTAMS TO MAXIMIZE SPECTRUMAND ACTIVITY AGAINST DRUG-RESISTANT RESPIRATORY-TRACT PATHOGENS - I -SYNERGY STUDIES OF AMOXICILLIN AND CEFIXIME WITH STREPTOCOCCUS-PNEUMONIAE, Diagnostic microbiology and infectious disease, 31(2), 1998, pp. 373-376
Authors:
JONES RN
PFALLER MA
Citation: Rn. Jones et Ma. Pfaller, BACTERIAL-RESISTANCE - A WORLDWIDE PROBLEM, Diagnostic microbiology and infectious disease, 31(2), 1998, pp. 379-388
Authors:
JONES RN
BALLOW CH
SCHENTAG JJ
JOHNSON DM
DEINHART JA
Citation: Rn. Jones et al., IN-VITRO EVALUATION OF SPARFLOXACIN ACTIVITY AND SPECTRUM AGAINST 24,940 PATHOGENS ISOLATED IN THE UNITED-STATES AND CANADA, THE FINAL ANALYSIS, Diagnostic microbiology and infectious disease, 31(1), 1998, pp. 313-325
Authors:
PFALLER MA
JONES RN
MESSER SA
EDMOND MB
WENZEL RP
Citation: Ma. Pfaller et al., NATIONAL SURVEILLANCE OF NOSOCOMIAL BLOOD-STREAM INFECTION DUE TO CANDIDA-ALBICANS - FREQUENCY OF OCCURRENCE AND ANTIFUNGAL SUSCEPTIBILITY IN THE SCOPE PROGRAM, Diagnostic microbiology and infectious disease, 31(1), 1998, pp. 327-332
Authors:
PFALLER MA
MARCO F
MESSER SA
JONES RN
Citation: Ma. Pfaller et al., IN-VITRO ACTIVITY OF 2 ECHINOCANDIN DERIVATIVES, LY303366 AND MK-0991(L-743,792), AGAINST CLINICAL ISOLATES OF ASPERGILLUS, FUSARIUM, RHIZOPUS, AND OTHER FILAMENTOUS FUNGI, Diagnostic microbiology and infectious disease, 30(4), 1998, pp. 251-255
Authors:
JONES RN
Citation: Rn. Jones, IN-MEMORIAM - NEU,HAROLD,C., MD (1934-1998), Diagnostic microbiology and infectious disease, 30(3), 1998, pp. 143-143
Authors:
MARSHALL SA
WILKE WW
PFALLER MA
JONES RN
Citation: Sa. Marshall et al., STAPHYLOCOCCUS-AUREUS AND COAGULASE-NEGATIVE STAPHYLOCOCCI FROM BLOOD-STREAM INFECTIONS - FREQUENCY OF OCCURRENCE, ANTIMICROBIAL SUSCEPTIBILITY, AND MOLECULAR (MECA) CHARACTERIZATION OF OXACILLIN RESISTANCE INTHE SCOPE PROGRAM, Diagnostic microbiology and infectious disease, 30(3), 1998, pp. 205-214
Authors:
JONES RN
PFALLER MA
DOERN GV
ERWIN ME
HOLLIS RJ
Citation: Rn. Jones et al., ANTIMICROBIAL ACTIVITY AND SPECTRUM INVESTIGATION OF 8 BROAD-SPECTRUMBETA-LACTAM DRUGS - A 1997 SURVEILLANCE TRIAL IN 102 MEDICAL-CENTERS IN THE UNITED-STATES, Diagnostic microbiology and infectious disease, 30(3), 1998, pp. 215-228